• No results found

tuberous sclerosis

Depigmented Nevi: The Earliest Sign of Tuberous Sclerosis

Depigmented Nevi: The Earliest Sign of Tuberous Sclerosis

... Depigmented Nevi: The Earliest Sign of Tuberous Sclerosis.. Tile classical features of tuberous sclerosis.[r] ...

5

Aim: To study rare tuberous sclerosis with typical presentation. Methods & Objectives: Detail study case of genetic disorder tuberous sclerosis with

Aim: To study rare tuberous sclerosis with typical presentation. Methods & Objectives: Detail study case of genetic disorder tuberous sclerosis with

... Tuberous sclerosis complex (TSC) is a genetic disorder affecting cellular differentiation, proliferation, and migration early in development, resulting in a variety of hamartomatous lesions affecting vital ...

5

mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders

mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders

... Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder that affects multiple organ systems throughout the body. Dysregulation of the mammalian target of rapamycin (mTOR) pathway is ...

9

Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy

Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy

... Abstract: Tuberous sclerosis complex (TSC) is a relatively rare genetic disorder, affecting one in 6,000 births. Mammalian target of rapamycin (mTOR) inhibitors, such as everolimus, which have been ...

8

Everolimus improved renal function without reducing the size of a kidney angiomyolipoma in a patient with tuberous sclerosis complex: a case report

Everolimus improved renal function without reducing the size of a kidney angiomyolipoma in a patient with tuberous sclerosis complex: a case report

... with tuberous sclerosis complex associated with an angiomyolipoma that was first detected at 12 years of age and had enlarged to a size that completely filled the bilateral ...

6

Is mTOR inhibition a systemic treatment for tuberous sclerosis?

Is mTOR inhibition a systemic treatment for tuberous sclerosis?

... Bilateral facial angiofibromas are hamartomatous nodules of vascular and connective tissue, with a butterfly pattern over the malar eminences and nasal labial folds of the face [1]. Their frequency is about 80% in ...

7

Burden of renal angiomyolipomas associated with tuberous sclerosis complex: results of a patient and caregiver survey

Burden of renal angiomyolipomas associated with tuberous sclerosis complex: results of a patient and caregiver survey

... government, and non-government organizations. As Evidera employees, they work with a variety of companies and organizations and are expressly pro- hibited from receiving any payment or honoraria directly from these ...

9

Tuberous Sclerosis Complex: A Review with a Study of Eight Cases

Tuberous Sclerosis Complex: A Review with a Study of Eight Cases

... Tuberous Sclerosis Complex A Review with a Study of Eight Cases ORIGINAL ARTICLE Tuberous Sclerosis Complex A Review with a Study of Eight Cases A S Malik, DTCH* Z A M Hussin, MRCP* S R Shriwas, MS**[.] ...

10

Renal Cell Carcinoma in Patients With Tuberous Sclerosis

Renal Cell Carcinoma in Patients With Tuberous Sclerosis

... In contrast to most pa- tients with renal cell carcinoma, none of those associated with tuberous sclerosis were reported to.. have had metastatic disease during a median follow- up perio[r] ...

8

Possible Prevention of Tuberous Sclerosis Complex Lesions

Possible Prevention of Tuberous Sclerosis Complex Lesions

... Address correspondence to Katarzyna Kotulska, MD, PhD, Department of Science, Department of Neurology and Epileptology, The Children ’ s Memorial Health Institute, Al. Dzieci Polskich 20, 04-730 Warsaw, Poland. E-mail: ...

6

Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants

Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants

... FundinG: Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award ...

13

A Case Report on Tuberous Sclerosis with Associated Ectropion Uvea

A Case Report on Tuberous Sclerosis with Associated Ectropion Uvea

... for tuberous sclerosis were firstly established in ...International Tuberous Sclerosis Complex Consensus Conference held in Washington, these criteria were reviewed with the aim of presenting ...

8

An unusual case of congenital melanocytic nevus presenting as neurocutaneous melanoma coexisting with Tuberous Sclerosis complex: A case report

An unusual case of congenital melanocytic nevus presenting as neurocutaneous melanoma coexisting with Tuberous Sclerosis complex: A case report

... Our patient had congenital giant, hairy melanotic nevi of the skin (scalp) which had gradually progressed in size to a cutaneous scalp tumor indicative of melanoma. NCM is known to be associated with the other NCSs, such ...

5

A HYPERTENSIVE ENCEPHALOPATHY REVEALING A BOURNEVILLE TUBEROUS SCLEROSIS IN A INFANT

A HYPERTENSIVE ENCEPHALOPATHY REVEALING A BOURNEVILLE TUBEROUS SCLEROSIS IN A INFANT

... [21] Al-Saleem T, Wessner LL, Scheithauer BW, and al. Malignant tumors of the kidney, brain and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer 1998;83:2208–16. [22] ...

9

MR Imaging of Tuberous Sclerosis in Neonates and Young Infants

MR Imaging of Tuberous Sclerosis in Neonates and Young Infants

... nial tuberous sclerosis findings in early infancy is quite characteristic, the presence of a solitary or a few hyperintense lesions can pose a diagnostic ...noncalcified tuberous scle- rosis lesions ...

10

Genetics of tuberous sclerosis complex: implications for clinical practice

Genetics of tuberous sclerosis complex: implications for clinical practice

... Abstract: Tuberous sclerosis complex (TSC) is a multisystem disorder that results from hetero- zygous mutations in either TSC1 or TSC2. The primary organ systems that are affected include the brain, skin, ...

8

Tuberous sclerosis complex: everything old is new again

Tuberous sclerosis complex: everything old is new again

... Abstract Tuberous Sclerosis Complex (TSC) is a multi- organ genetic disease caused by loss of function of either the TSC1 (encodes hamartin) or TSC2 (encodes tuberin) ...

9

Cystlike white matter lesions in tuberous sclerosis

Cystlike white matter lesions in tuberous sclerosis

... of tuberous sclerosis have been long recognized and well described on computed tomographic (CT) and magnetic res- onance (MR) imaging studies ...with tuberous sclerosis, and we describe our ...

7

Clinical and Genotype Studies of Cardiac Tumors in 154 Patients With Tuberous Sclerosis Complex

Clinical and Genotype Studies of Cardiac Tumors in 154 Patients With Tuberous Sclerosis Complex

... OBJECTIVE. Tuberous sclerosis complex is an autosomal dominant disorder in which hamartomas occur in several ...with tuberous sclerosis ...of tuberous sclerosis ...

8

Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial

Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial

... International tuberous sclerosis complex consensus conference held in 2012 recommended mTOR inhibitors as the first-line treatment for RAML when enlarged to 3 cm or more, even when asymptomatic ...

9

Show all 3178 documents...

Related subjects